share_log

Wells Fargo Maintains Overweight on Avrobio, Lowers Price Target to $2

Benzinga ·  Jul 13, 2023 07:56

Wells Fargo analyst Yanan Zhu maintains Avrobio (NASDAQ:AVRO) with a Overweight and lowers the price target from $2.5 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment